These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1331590)

  • 41. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
    Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
    J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder.
    Corsi M; Pietra C; Toson G; Trist D; Tuccitto G; Artibani W
    Br J Pharmacol; 1991 Nov; 104(3):719-25. PubMed ID: 1797331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-HT3 receptor blocking properties of the antiparkinsonian agent, talipexole.
    Nishio H; Kohno Y; Fujii A; Negishi Y; Inoue A; Nakata Y
    Gen Pharmacol; 1996 Jul; 27(5):779-85. PubMed ID: 8842679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on serotonin (5-HT)3-receptor antagonist effects of enantiomers of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Kamato T; Ito H; Suzuki T; Miyata K; Honda K
    Jpn J Pharmacol; 1995 Mar; 67(3):185-94. PubMed ID: 7630036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM; Costall B; Naylor RJ
    J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
    Barrett RJ; Appell KC; Kilpatrick BF; Proakis AG; Nolan JC; Walsh DA
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.
    Fox AJ; Morton IK
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):8-15. PubMed ID: 1723152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea pig proximal colon in vitro?
    Sevcík J; Ruzicka V; Slánsky J; Masek K
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):421-30. PubMed ID: 8900213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity.
    Alvarez-Guerra M; d'Alché-Birée F; Wolf WA; Vargas F; Dib M; Garay RP
    Psychopharmacology (Berl); 2000 Jan; 147(4):412-7. PubMed ID: 10672635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of Y-25130, a selective 5-HT3 receptor antagonist, on the intestinal fluid secretion in rats].
    Ooe M; Asano K; Haga K; Setoguchi M
    Nihon Yakurigaku Zasshi; 1993 May; 101(5):299-307. PubMed ID: 8330800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium.
    Medhurst AD; Kaumann AJ
    Br J Pharmacol; 1993 Nov; 110(3):1023-30. PubMed ID: 8298790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
    Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
    Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.